Tilray Inc sell ReynadJ
Start price
09.11.24
/
0%
€1.39
Target price
09.11.25
€1.00
Performance (%)
-19.40%
End price
10.11.25
€1.12
Summary
This prediction ended on 10.11.25 with a price of €1.12. The price of Tilray Inc decreased from the start of the prediction. Compared to the start price this resulted in a performance of -19.40%. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tilray Inc | -14.105% | -14.105% | -78.620% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to ReynadJ what are the pros and cons of Tilray Inc for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad rating
Little Investments for future growth
Comments by ReynadJ for this prediction
In the thread Tilray Inc diskutieren
Sell mit Kursziel 1,0
In the thread Trading Tilray Inc
Die von ReynadJ gewählte maximale Laufzeit wurde überschritten